BARCLAYS PLC

Holdings History for Kezar Life Sciences Inc - COMMON-STOCK (KZR)

Symbol: KZR on Nasdaq
Investment type: Equity - Shares of Stock
Class: COMMON-STOCK

Shares, Excluding Options vs Price

Value, Excluding Options

Barclays PLC ownership in Kezar Life Sciences Inc COMMON-STOCK (KZR)

2025-03-21 - Barclays PLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of shares of Kezar Life Sciences Inc COMMON-STOCK (KZR). This represents percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Barclays PLC								13G/A	9/30/2024	21 Mar 2025 17:54:29
Ramya Rao								13G/A	9/30/2024	14 Nov 2024 12:24:41

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2024		0%	$0	0	-50,118	-100%		Q2 2024
3/31/2024	0%	0%	$45K	50.1K	-47,919	-48.9%	$0.90	Q1 2024
12/31/2023	0%	+0%	$93K	98K	+85,445	+679%	$0.95	Q4 2023
9/30/2023	0%	0%	$15K	12.6K	-1,633	-11.5%	$1.19	Q3 2023
6/30/2023	0%	0%	$35K	14.2K	-814,703	-98.3%	$2.46	Q2 2023
3/31/2023	0%	+0%	$2.59M	829K	+641,437	+342%	$3.13	Q1 2023
12/31/2022	0%	+0%	$1.32M	187K	+34,277	+22.4%	$7.04	Q4 2022
9/30/2022	0%	+0%	$1.32M	153K	+149,189	+3707%	$8.61	Q3 2022
6/30/2022	0%	0%	$33K	4.03K	-2,124	-34.5%	$8.20	Q2 2022
3/31/2022	0%	0%	$102K	6.15K	-36,313	-85.5%	$16.59	Q1 2022
12/31/2021	0%	+0%	$710K	42.5K	+10,470	+32.7%	$16.72	Q4 2021
9/30/2021	0%	+0%	$277K	32K	+9,657	+43.2%	$8.66	Q3 2021
6/30/2021	0%	0%	$122K	22.3K	-22,040	-49.7%	$5.46	Q2 2021
3/31/2021	0%	+0%	$264K	44.4K	+16,065	+56.7%	$5.95	Q1 2021
12/31/2020	0%	0%	$148K	28.3K	-3,806	-11.9%	$5.23	Q4 2020
9/30/2020	0%	0%	$155K	32.1K	-1,802	-5.31%	$4.83	Q3 2020
6/30/2020	0%	+0%	$175K	33.9K	+5,612	+19.8%	$5.16	Q2 2020
3/31/2020	0%	0%	$124K	28.3K	-5,500	-16.3%	$4.38	Q1 2020
12/31/2019	0%	+0%	$135K	33.8K	+7,867	+30.3%	$3.99	Q4 2019
9/30/2019	0%	+0%	$85K	25.9K	+902	+3.6%	$3.28	Q3 2019
6/30/2019	0%	+0%	$193K	25K	+21,479	+604%	$7.71	Q2 2019
3/31/2019	0%	+0%	$63K	3.56K	+3,558	NEW	$17.71	Q1 2019
12/31/2018		0%	$0	0	-1,927	-100%		Q4 2018
9/30/2018	0%	+0%	$41K	1.93K	+1,927	NEW	$21.28	Q3 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.